DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1
- PMID: 15464849
- DOI: 10.1016/j.virol.2004.07.031
DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1
Abstract
DNA vaccines expressing the envelope (Env) of the human immunodeficiency virus type 1 (HIV-1) have been relatively ineffective at generating high-titer, long-lasting, neutralizing antibodies in a variety of animal models. In this study, DNA vaccines were constructed to express a fusion protein of the soluble human CD4 (sCD4) and the gp120 subunit of the HIV-1 envelope. To enhance the immunogenicity of the expressed fusion protein, three copies of the murine C3d (mC3d3) were added to the carboxyl terminus of the complex. Monoclonal antibodies that recognize CD4-induced epitopes on gp120 efficiently bound to sCD4-gp120 or sCD4-gp120-mC3d3. In addition, both sCD4-gp120 and sCD4-gp120-mC3d3 bound to cells expressing appropriate coreceptors in the absence of cell surface hCD4. Mice (BALB/c) vaccinated with DNA vaccines expressing either gp120-mC3d3 or sCD4-gp120-mC3d3 elicited antibodies that neutralized homologous virus infection. However, the use of sCD4-gp120-mC3d3-DNA elicited the highest titers of neutralizing antibodies that persisted after depletion of anti-hCD4 antibodies. Interestingly, only mice vaccinated with DNA expressing sCD4-gp120-mC3d3 had antibodies that elicited cross-protective neutralizing antibodies. The fusion of sCD4 to the HIV-1 envelope exposes neutralizing epitopes that elicit broad protective immunity when the fusion complex is coupled with the molecular adjuvant, C3d.
Similar articles
-
HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.Vaccine. 2006 Jun 29;24(26):5442-51. doi: 10.1016/j.vaccine.2006.03.063. Epub 2006 Apr 3. Vaccine. 2006. PMID: 16621193
-
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.AIDS Res Hum Retroviruses. 2004 Nov;20(11):1259-68. doi: 10.1089/aid.2004.20.1259. AIDS Res Hum Retroviruses. 2004. PMID: 15588348 Free PMC article.
-
Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.Vaccine. 2004 Apr 16;22(13-14):1764-72. doi: 10.1016/j.vaccine.2003.09.054. Vaccine. 2004. PMID: 15068860
-
GP120: target for neutralizing HIV-1 antibodies.Annu Rev Immunol. 2006;24:739-69. doi: 10.1146/annurev.immunol.24.021605.090557. Annu Rev Immunol. 2006. PMID: 16551265 Review.
-
Janusin: new molecular design for bispecific reagents.Int J Cancer Suppl. 1992;7:51-2. Int J Cancer Suppl. 1992. PMID: 1428404 Review.
Cited by
-
Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.J Virol. 2006 Apr;80(8):4068-78. doi: 10.1128/JVI.80.8.4068-4078.2006. J Virol. 2006. PMID: 16571823 Free PMC article.
-
Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.Adv Pharmacol. 2007;55:33-97. doi: 10.1016/S1054-3589(07)55002-7. Adv Pharmacol. 2007. PMID: 17586312 Free PMC article. Review.
-
Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.Immunology. 2008 Feb;123(2):228-38. doi: 10.1111/j.1365-2567.2007.02692.x. Epub 2007 Aug 30. Immunology. 2008. PMID: 17764451 Free PMC article.
-
A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets.PLoS One. 2009 Jun 24;4(6):e6032. doi: 10.1371/journal.pone.0006032. PLoS One. 2009. PMID: 19554101 Free PMC article.
-
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.Virol J. 2010 May 12;7:95. doi: 10.1186/1743-422X-7-95. Virol J. 2010. PMID: 20462412 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
